Condensed Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Operating expenses
Research and development	$ 29,193	$ 13,644	$ 78,990	$ 32,760
General and administrative	9,577	2,638	22,573	8,269
Total operating expenses	38,770	16,282	101,563	41,029
Loss from operations	(38,770)	(16,282)	(101,563)	(41,029)
Interest income	4,355	880	11,784	1,493
Interest expense	(32)	(50)	(115)	(140)
Other expense, net	(45)	(13)	(94)	(23)
Total other income, net	4,278	817	11,575	1,330
Net loss	(34,492)	(15,465)	(89,988)	(39,699)
Other comprehensive income
Unrealized gain on available-for-sale marketable securities, net	190	5	149	31
Total other comprehensive income	190	5	149	31
Net loss and other comprehensive income (loss)	$ (34,302)	$ (15,460)	$ (89,839)	$ (39,668)
Net loss per share attributable to common stockholders, basic	$ (0.8)	$ (23.27)	$ (2.45)	$ (62.75)
Net loss per share attributable to common stockholders, diluted	$ (0.8)	$ (23.27)	$ (2.45)	$ (62.75)
Weighted-average shares of common stock outstanding, basic	43,155,858	664,656	36,702,183	632,624
Weighted-average shares of common stock outstanding, diluted	43,155,858	664,656	36,702,183	632,624